MedPath

UNIVERSITY OF FLORIDA

UNIVERSITY OF FLORIDA logo
🇺🇸United States
Ownership
Private
Established
1853-01-01
Employees
10K
Market Cap
-
Website
http://www.ufl.edu

Music of Choice to Decrease Anxiety During Radiation Treatment

Not Applicable
Completed
Conditions
Cancer
Anxiety
Interventions
Other: Music
First Posted Date
2018-05-17
Last Posted Date
2020-03-13
Lead Sponsor
University of Florida
Target Recruit Count
135
Registration Number
NCT03527225
Locations
🇺🇸

University of Florida Health Cancer Center, Gainesville, Florida, United States

Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine

Phase 2
Completed
Conditions
Liver Transplant
Kidney Transplant
Interventions
Other: PPM-based Computation Assisted Drug Dosing
Drug: Tacrolimus
First Posted Date
2018-05-17
Last Posted Date
2021-12-10
Lead Sponsor
University of Florida
Target Recruit Count
62
Registration Number
NCT03527238
Locations
🇺🇸

UCLA, Los Angeles, California, United States

🇸🇬

National University of Singapore, Singapore, Singapore

🇺🇸

UF Health at the University of Florida, Gainesville, Florida, United States

Modifiable Work and Movement Solutions Low Back Pain in Seafood Workers

Not Applicable
Completed
Conditions
Chronic Low Back Pain
Interventions
Behavioral: Ergonomic and movement modifications
First Posted Date
2018-05-14
Last Posted Date
2022-11-17
Lead Sponsor
University of Florida
Target Recruit Count
37
Registration Number
NCT03524378
Locations
🇺🇸

Cedar Key Aquaculture Association, Cedar Key, Florida, United States

🇺🇸

UF Health, Gainesville, Florida, United States

Clinical Practice Guidelines for Neck and Low Back Pain in Outpatient Physical Therapy

Not Applicable
Completed
Conditions
Low Back Pain
Neck Pain
Interventions
Behavioral: Clinical Practice Guideline Implementation
Other: Standard Care
First Posted Date
2018-05-14
Last Posted Date
2023-10-23
Lead Sponsor
University of Florida
Target Recruit Count
1441
Registration Number
NCT03523793
Locations
🇺🇸

Brooks Rehabilitation, Jacksonville, Florida, United States

Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation

Phase 1
Completed
Conditions
Bone Marrow Failure Syndrome
Sickle Cell Disease
Diamond Blackfan Anemia
Thalassemia
Acquired Neutropenia in Newborn
Acquired Anemia Hemolytic
Acquired Thrombocytopenia
Hemophagocytic Lymphohistiocytoses
Wiskott-Aldrich Syndrome
Chronic Granulomatous Disease
Interventions
Drug: Thiotepa--single daily dose
Drug: Thiotepa--escalated dose
First Posted Date
2018-05-01
Last Posted Date
2023-09-15
Lead Sponsor
University of Florida
Target Recruit Count
6
Registration Number
NCT03513328
Locations
🇺🇸

UF Health Shands Children's Hospital, Gainesville, Florida, United States

Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study

Phase 4
Completed
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2018-04-06
Last Posted Date
2020-09-16
Lead Sponsor
University of Florida
Target Recruit Count
14
Registration Number
NCT03489863
Locations
🇺🇸

University of Florida, Jacksonville, Florida, United States

Pain Modulatory Profiles in Massage for Healthy Participants

Not Applicable
Completed
Conditions
Healthy
Musculoskeletal Pain
Interventions
Other: Pain Free Massage
Other: Coldpressor
Other: Pain Inducing Massage
First Posted Date
2018-04-06
Last Posted Date
2018-12-13
Lead Sponsor
University of Florida
Target Recruit Count
60
Registration Number
NCT03490474
Locations
🇺🇸

UF Health, Gainesville, Florida, United States

Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy

Not Applicable
Completed
Conditions
Seizure Disorder
Epilepsy
Interventions
Behavioral: Medication Adherence
Behavioral: Seizure Documentation
Behavioral: Memory Improvement
Behavioral: Stress Management
First Posted Date
2018-03-30
Last Posted Date
2024-12-20
Lead Sponsor
University of Florida
Target Recruit Count
332
Registration Number
NCT03484039
Locations
🇺🇸

UF Health Jacksonville, Jacksonville, Florida, United States

A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma

Phase 2
Active, not recruiting
Conditions
Pancreatic Adenocarcinoma
Interventions
Drug: Liposomal Irinotecan
Drug: FOLFOX regimen
First Posted Date
2018-03-29
Last Posted Date
2023-11-18
Lead Sponsor
University of Florida
Target Recruit Count
45
Registration Number
NCT03483038
Locations
🇺🇸

Orlando Health UF Health Cancer Center, Orlando, Florida, United States

🇺🇸

University of Florida, Gainesville, Florida, United States

🇺🇸

Tallahassee Memorial Health Care, Tallahassee, Florida, United States

and more 1 locations

Tobacco Use Treatment in Cancer Patients

Phase 4
Completed
Conditions
Smoking, Cigarette
Interventions
Drug: Nicotine Replacement Therapy
Other: Referral to AHEC/Quitline
First Posted Date
2018-03-29
Last Posted Date
2020-05-22
Lead Sponsor
University of Florida
Target Recruit Count
90
Registration Number
NCT03482583
Locations
🇺🇸

University of Florida, Gainesville, Florida, United States

🇺🇸

UF Health Medical Oncology, Gainesville, Florida, United States

🇺🇸

UF Health Radiation Oncology, Gainesville, Florida, United States

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath